[CAS NO. 147-84-2] Ditiocarb
PRODUCTS SPECIFICATIONS [147-84-2]
DESCRIPTION [147-84-2]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 149.28 |
| Molecular Formula | C5H11NS2 |
| SMILES | SC(N(CC)CC)=S |
2 Publications Citing Use of MCE
Summary
In Vitro
Ditiocarb reacts with the Cu 2+ solution giving a complex of copper diethyldithiocarbamate, which enhances the rate of cementation [1] . Ditiocarb is an agent with strong antioxidant capacity and chelating activities [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Ditiocarb improves the depressed immune responses of newborn and aged mice. Ditiocarb prevents cisplatin nephrotoxicity in animals without reducing the antitumor activity.
In that AIDS model, Ditiocarb reduces lymphadenopathy and hypergammaglobulinemia, restores immunocompetence, and prolongs survival
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
References
- [1] Abeer A.El-Saharty, et al. Sodium diethyldithiocarbamate as accelerator of the rate of copper cementation. The Egyptian Journal of Aquatic Research. 2015 Dec, Volume 41(4):289-293.
- [2] Hersh EM, et al. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. JAMA. 1991 Mar 27;265(12):1538-44.
- [3] Dufour P, et al. Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy. 1993;6(1):9-12.